Henrik Dimke
banner
hdimke.bsky.social
Henrik Dimke
@hdimke.bsky.social
Professor at University of Southern Denmark | Renal Physiologist - aiming to understand how kidneys work | Research Politics Nerd | Views are my own
Excited to share the latest publication from our lab. Now out in JASN @asnpublications.bsky.social, a leading journal in the field journals.lww.com/jasn/abstrac...

Our study examines how the calcium-sensing receptor (CASR) in the kidney helps protect against high blood calcium (hypercalcemia).
Calcium-Sensing Receptor in the Thick Ascending Limb and... : Journal of the American Society of Nephrology
he TAL.Activation of the CASR did not affect the driving force generated by transcellular NaCl transport across the TAL. Background The parathyroid calcium-sensing receptor (CASR) controls the rele...
journals.lww.com
March 10, 2025 at 11:48 AM
Reposted by Henrik Dimke
Also published today
The Boston first in human kidney xenotransplantation case report

@nejm.org #ISNWCN

www.nejm.org/doi/full/10....
February 7, 2025 at 9:56 AM
Looking much forward to see the outcome from this exciting development www.nature.com/articles/d41...
The science behind the first pig-organ transplant trial in humans
The small trial will help to establish whether kidneys from genetically modified pigs can be transplanted into people safely and effectively.
www.nature.com
February 6, 2025 at 7:08 PM
Reposted by Henrik Dimke
Nature research paper: A neoantigen vaccine generates antitumour immunity in renal cell carcinoma

https://go.nature.com/4gtHiuX
A neoantigen vaccine generates antitumour immunity in renal cell carcinoma - Nature
A phase I trial of a neoantigen-targeting personalized cancer vaccine led to durable and polyfunctional T cell responses and antitumour recognition, and was associated with no recurrence in patients with high-risk clear cell renal cell carcinoma.
go.nature.com
February 6, 2025 at 6:55 PM